US Drug Recall Register
Class III · Low risk Terminated Initiated Dec 20, 2018 (8 years ago)

Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC 43975-253-14) bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ

Recalling firm
Amerigen Pharmaceuticals Inc.
NDC code
43975-253-05
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0344-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Temozolomide recalls

See all